INS and COVID-19: In addition, attention has focused recently on possible autoimmune components of T2D, and it has been reported that genetically susceptible children have increased development of anti–β cell antibodies following COVID-19.29,30 In addition, SARS-CoV-2 may have the ability to selectively infect human pancreatic β cells,31 and if this triggers apoptosis, the ability of the pancreas to secrete insulin may be impaired.